Lackritz EM, Satten GA, Aberle-Grasse J.
et al. Estimated risk of transmission of the human immunodeficiency virus
by screened blood in the United States. N Engl J Med.1995;333:1721-1725.
Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med.1996;334:1685-1690.
Busch MP, Lee LL, Satten GA.
et al. Time course of detection of viral and serologic markers preceding human
immunodeficiency virus type 1 seroconversion. Transfusion.1995;35:91-97.
Recommendations for donor screening with a licensed test for HIV-1
antigen [memorandum]. Rockville, Md: Food and Drug Administration, Center for Biologics
Evaluation and Research; August 8, 1995.
Clark SJ, Saag MS, Decker WD.
et al. High titers of cytopathic virus in plasma of patients with symptomatic
primary HIV-1 infection. N Engl J Med.1991;324:954-960.
Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency
virus type 1 infection. N Engl J Med.1991;324:961-964.
US Public Health Service guidelines for testing and counseling blood
and plasma donors for human immunodeficiency virus type 1 antigen. MMWR Morb Mortal Wkly Rep.1996;45(RR-2):1-9.
Busch MP, Satten GA, Herman SA.
et al. HIV plasma RNA for confirmation of HIV-1 p24 ag/anti-HIV reactivity
in seroconverting donors [abstract]. Transfusion.1996;36(suppl):41S. Abstract S163.
Brown AE, Jackson B, Fuller SA.
et al. Viral RNA in the resolution of human immunodeficiency virus type 1
diagnostic serology. Transfusion.1997;37:926-929.
FDA holds workshops on blood donor suitability, leukocyte reduction,
and NAT. AABB Wkly Rep.December 17, 1999;5:3.
Report of the Interorganizational Task Force on
Nucleic Acid Amplification Testing of Blood Donors. Nucleic acid amplification testing of blood donors for transfusion-transmitted
infectious diseases. Transfusion.2000;40:143-159.
Kleinman SH, Busch MP. Risks of transfusion transmitted infection: direct estimation and mathematical
modeling. In: Contreras M, ed. Best Practice and Research
in Clinical Haematology. London, England: Bailliere Tindall Publishing.
Delwart EL, Shpaer EG, Louwagie J.
et al. Genetic relationships determined by a DNA heteroduplex mobility assay. Science.1993;262:1257-1261.
HIV-1/HCV TMA Assay, 5000 Test Kit [draft package insert]. Emeryville, Calif: Chiron Procleix; 1998.
COBAS AmpliScreen HIV-1 Test, v1.5 [draft package insert]. Pleasanton, Calif: Roche Molecular Systems, Inc; 1999.
Schochetman GS, Subbarao S, Kalish ML. Viral Genome Methods. Boca Raton, Fla: CRC Press Inc; 1996:25-41.
Ginocchio CC, Tetali S, Washburn D.
et al. Comparison of levels of human immunodeficiency virus type 1 RNA in
plasma as measured by the NucliSens nucleic acid sequence-based amplification
and Quantiplex branched-DNA assays. J Clin Microbiol.1999;37:1210-1212.
Update: serologic testing for HIV-1 antibody—United States, 1988
and 1989. MMWR Morb Mortal Wkly Rep.1990;39:380-383.
Kleinman S, Busch MP, Hall L.
et al. False-positive HIV-1 test results in a low-risk screening setting of
voluntary blood donation. JAMA.1998;280:1080-1085.
McNearney T, Westervelt P, Thielan BJ.
et al. Limited sequence heterogeneity among biologically distinct human immunodeficiency
virus type 1 isolates from individuals involved in a clustered infectious
outbreak. Proc Natl Acad Sci U S A.1990;87:1917-1921.
Wolfs TFW, Zwart G, Bakker M, Goudsmit J. HIV-1 genomic RNA diversification following sexual and parenteral virus
Zhu T, Mo H, Wang N.
et al. Genotypic and phenotypic characterization of HIV-1 patients with primary
Zhang LQ, MacKenzie P, Cleland A.
et al. Selection for specific sequences in the external envelope protein of
human immunodeficiency virus type 1 upon primary infection. J Virol.1993;67:3345-3356.
Diaz RS, Zhang L, Busch MP.
et al. Divergence of HIV-1 quasispecies in an epidemiologic cluster. AIDS.1997;11:415-422.
Laperche S, Moreau P, Lair J, Courouce AM. Two successive HIV contaminations from subjects in the window period. AIDS.1998;12:1397-1398.
Busch MP, Stramer SL, Kleinman SH. Evolving applications of nucleic acid amplification assays for prevention
of virus transmission by blood components and derivatives. In: Garratty G, ed. Applications of Molecular Biology
to Blood Transfusion Medicine. Bethesda, Md: American Association of
Blood Banks; 1997:123-176.
Cardoso MS, Koerner K, Kubanek B. Mini-pool screening by nucleic acid testing for hepatitis B virus,
hepatitis C virus, and HIV. Transfusion.1998;38:905-907.
LeCorfec E, Le Pont F, Tuckwell HC.
et al. Direct HIV testing in blood donations. Transfusion.1999;39:1141-1144.
Yerly S, Pedrocchi M, Perrin L. The use of polymerase chain reaction in plasma pools for the concomitant
detection of hepatitis C virus and HIV type 1 RNA. Transfusion.1998;38:908-914.
Blood organizations outline plans for nucleic acid testing at FDA workshop. America's Blood Centers' Newsletter.September 25, 1998:9-10.
Murthy KK, Henrard DR, Eichberg JW.
et al. Redefining the HIV-infectious window period in the chimpanzee model. Transfusion.1999;39:688-693.